16:58 EST MiNK Therapeutics (INKT) files $150M mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INKT:
- Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating
- MiNK Therapeutics reports updated clinical results on agenT-797
- MiNK Therapeutics Appoints Dr. John Holcomb as Director
- MiNK Therapeutics appoints John Holcomb to board of directors
- MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases